CDXS - Codexis reports Q1 results reiterates FY 2023 revenue guidance
2023-05-04 16:25:12 ET
- Codexis press release ( NASDAQ: CDXS ): Q1 Non-GAAP EPS of -$0.39.
- Revenue of $12.98M (-63.3% Y/Y) misses by $1.11M .
- CDXS reiterated its 2023 total revenue guidance range of $63 million to $68 million, excluding enzyme sales related to Paxlovid. The consensus estimate is $74.52M.
For further details see:
Codexis reports Q1 results, reiterates FY 2023 revenue guidance